Gilead Sciences Acquires CV Therapeutics
Gilead Sciences acquired CV Therapeutics for $1.4B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Gilead Sciences
- Acquired Company
- CV Therapeutics
- Price
- $1.4B
- Acquisition Type
- Acquisition
- Announced
- April 17, 2009
Canonical: https://fsome.com/acquisitions/gilead-sciences-acquires-cv-therapeutics-8142706 · For the full deal terms, timeline, and press references, please enable JavaScript.